Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.ECOENV.2010.08.010 | ||||
| Año | 2010 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
A study was done to investigate the effect of parasitism on patterns of doramectin (DRM) fecal elimination in lambs. Fourteen Suffolk Down parasitized lambs (26.9 +/- 1.5 kg body weight: bw) were purposely selected for the study. Seven pairs of lambs were allocated into two experimental groups. Group I (non-parasitized) was pre-treated with 3 repeated administrations of 5 mg/kg bw of fenbendazole to maintain a non-parasitized condition. In Group II (parasitized), the lambs did not receive any anthelmintic treatment. After 85 d of the pre-treatment period, both groups were treated with a subcutaneous injection of 200 mu g/kg bw of DRM. Fecal samples were collected at different times between 85 d before and 60 d after the DRM treatment, for both parasitological and chromatographic analysis. Samples were analyzed by high-performance liquid chromatography (HPLC) with fluorescence detection. Data of DRM concentrations were expressed as wet weight. A non-linear pharmacokinetic analysis was performed and results were compared using the Mann Whitney test. Fecal maximum concentrations (C-max) of DRM were 1.37 +/- 0.19 mu g/g (parasitized group) and 0.86 +/- 0.15 mu g/g (non-parasitized group) observed at the time of the maximum concentration (T-max) of 2.1 +/- 0.4 and 3.1 +/- 0.3 d, respectively. Differences in C-max values were significant (P < 0.05). The accumulated elimination of DRM in feces, expressed as the percentage of DRM total dose, was 67.1% in the parasitized group, whereas in the non-parasitized group it was 56.5%. Our results showed that gastrointestinal parasitic diseases can modify the patterns of DRM fecal elimination, when the drug is administered by subcutaneous route in lambs. (C) 2010 Elsevier Inc. All rights reserved.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Perez, Ruben | Hombre |
Universidad de Concepción - Chile
|
| 2 | PALMA-CEPPI, CRISTIAN ANDRES | Mujer |
Universidad de Concepción - Chile
|
| 3 | CABEZAS-AVILA, OSCAR IGNACIO | Hombre |
Universidad de Concepción - Chile
|
| 4 | RUBILAR-CONTRERAS, LUIS ERNESTO | Hombre |
Universidad de Concepción - Chile
|
| 5 | Arboix, M. | Mujer |
UNIV AUTONOMA BARCELONA - España
Universitat Autònoma de Barcelona - España |
| Fuente |
|---|
| CONICYT-Chile |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Fondo Nacional de Desarrollo CientÃfico y Tecnológico |
| Agradecimiento |
|---|
| The gift of DRM standard by Pfizer Animal Health, Chile is greatly appreciated. Supported by Grant FONDECYT 1030609, CONICYT-Chile. Authors thank Dr. Marcos A. Munoz Domon for his valuable critical review of the article. |
| The gift of DRM standard by Pfizer Animal Health, Chile is greatly appreciated. Supported by Grant FONDECYT 1030609 , CONICYT-Chile. Authors thank Dr. Marcos A. Muñoz Domon for his valuable critical review of the article. |